Antibody Responses in Contacts of COVID-19 Patients
Antibody Responses in Contacts of COVID-19 Sufferers
The SARS-CoV-2 belongs to the genus β which has been confirmed to be extremely infectious by analysis. (https://www.who.int/emergencies/ illnesses/novel-coronavirus-2019/situation-reports).
The 4 main structural proteins of coronavirus are the spike floor glycoprotein (S), small envelope protein (E), matrix protein (M), and nucleocapsid protein (N). The spike protein (S) of coronavirus is a kind I transmembrane glycoprotein and mediates the doorway to human respiratory epithelial cells by interacting with cell floor receptor angiotensin-converting enzyme 2 (ACE2) .
The S protein incorporates distinct useful domains close to the amino (S1) and carboxy (S2) termini, the peripheral S1 portion can independently bind mobile receptors whereas the integral membrane S2 portion is required to mediate fusion of viral and mobile membranes .
The nucleocapsid protein (N) varieties complexes with genomic RNA, interacts with the viral membrane protein throughout virion meeting and performs a important position in enhancing the effectivity of virustranscription and meeting .
The prognosis of COVID-19 relies primarily on scientific traits, CT imaging and some laboratory assessments. Though some signs and laboratory parameters have indicative values in confirmed sufferers, they aren’t distinctive to SARSCoV-2 an infection.
Essentially the most used and dependable check for prognosis of COVID-19 has been the RT-PCR check carried out utilizing nasopharyngeal swabs.
A wide range of RNAgenetargets are utilized by completely different producers, with most assessments concentrating on 1 or extra of the envelope (env), nucleocapsid (N), spike (S), RNA-dependent RNA polymerase (RdRp), and ORF1 genes .
Human Galectin-1 |
|||
| MBS691583-5x005mg | MyBiosource | 5x0.05mg | EUR 1245 |
Human Galectin-1 |
|||
| MBS691972-001mg | MyBiosource | 0.01mg | EUR 300 |
Human Galectin-1 |
|||
| MBS691972-005mg | MyBiosource | 0.05mg | EUR 450 |
Human Galectin-1 |
|||
| MBS691972-5x005mg | MyBiosource | 5x0.05mg | EUR 1725 |
Galectin-1， Human |
|||
| E34M148H | EnoGene | 5 μg | EUR 155 |
Galectin-1 Human |
|||
| GWB-DAB7E1 | GenWay Biotech | 0.05 mg | Ask for price |
Galectin-1, Human |
|||
| MBS8575305-0005mg | MyBiosource | 0.005mg | EUR 245 |
Galectin-1, Human |
|||
| MBS8575305-5x0005mg | MyBiosource | 5x0.005mg | EUR 940 |
Mouse anti Human Galectin-1 Antibody, Mouse MAb |
|||
| MBS2543309-006mL | MyBiosource | 0.06mL | EUR 250 |
Mouse anti Human Galectin-1 Antibody, Mouse MAb |
|||
| MBS2543309-012mL | MyBiosource | 0.12mL | EUR 370 |
Mouse anti Human Galectin-1 Antibody, Mouse MAb |
|||
| MBS2543309-02mL | MyBiosource | 0.2mL | EUR 550 |
Human Galectin( Galectin) Elisa Kit |
|||
| EK711568 | AFG Bioscience LLC | 96 Wells | EUR 0.18 |
Human Galectin-1 (Gal-1) Antibody |
|||
| 30005-05111 | AssayPro | 150 ug | EUR 215 |
RABBIT ANTI HUMAN GALECTIN-3:Biotin |
|||
| MBS222930-005mg | MyBiosource | 0.05mg | EUR 655 |
RABBIT ANTI HUMAN GALECTIN-3:Biotin |
|||
| MBS222930-5x005mg | MyBiosource | 5x0.05mg | EUR 2780 |
Rabbit Anti-Human Galectin-1 |
|||
| 102-PA131 | Angio Proteomie | 100ug | EUR 240 |
Anti-Human Galectin-1 Antibody |
|||
| 102-P131 | ReliaTech | 100 µg | EUR 245.7 |
|
Description: Galectin-1, also known as L14, BHL and galaptin, is a monomeric or homodimeric prototype galectin that is expressed in a variety of cells and tissues including muscle, heart, liver, prostate, lymph nodes, spleen, thymus, placenta, testis, retina, macrophages, B cells, T cells, dendritic cells, and tumor cells. It preferentially binds laminin, fibronectin, 90K/Mac2BP, CD45, CD43, CD7, CD2, CD3, and ganglioside GM1. Galectin-1 modulates cell growth and proliferation, either positively or negatively, depending on the cell type and activation status. It controls cell survival by inducing apoptosis of activated T cells and immature thymocytes. It modulates cytokine secretion by inducing Th2 type cytokines and inhibiting proinflammatory cytokine production. Galectin1 can also modulate cel-lcell as well as cell-lmatrix interactions and depending on the cell type and developmental stage, promote cell attachment or detachment. Galectin-1 has immunosuppressive and anti-inflammatory properties and has been shown to suppress acute and chronic inflammation and autoimmunity. Human and mouse galectin1 share about 88% amino acid sequence similarity. |
|||
Anti-Human Galectin-1 Antibody |
|||
| 102-PA131AG | ReliaTech | 50 µg | EUR 157.5 |
|
Description: Galectin-1, also known as L14, BHL and galaptin, is a monomeric or homodimeric prototype galectin that is expressed in a variety of cells and tissues including muscle, heart, liver, prostate, lymph nodes, spleen, thymus, placenta, testis, retina, macrophages, B cells, T cells, dendritic cells, and tumor cells. It preferentially binds laminin, fibronectin, 90K/Mac2BP, CD45, CD43, CD7, CD2, CD3, and ganglioside GM1. Galectin-1 modulates cell growth and proliferation, either positively or negatively, depending on the cell type and activation status. It controls cell survival by inducing apoptosis of activated T cells and immature thymocytes. It modulates cytokine secretion by inducing Th2 type cytokines and inhibiting proinflammatory cytokine production. Galectin1 can also modulate cel-lcell as well as cell-lmatrix interactions and depending on the cell type and developmental stage, promote cell attachment or detachment. Galectin-1 has immunosuppressive and antiinflammatory properties and has been shown to suppress acute and chronic inflammation and autoimmunity. Human and mouse galectin1 share about 88% amino acid sequence similarity. |
|||
Anti-Human Galectin-1 Antibody |
|||
| 102-PA131S | ReliaTech | 100 µg | EUR 126 |
|
Description: Galectin-1, also known as L14, BHL and galaptin, is a monomeric or homodimeric prototype galectin that is expressed in a variety of cells and tissues including muscle, heart, liver, prostate, lymph nodes, spleen, thymus, placenta, testis, retina, macrophages, B cells, T cells, dendritic cells, and tumor cells. It preferentially binds laminin, fibronectin, 90K/Mac2BP, CD45, CD43, CD7, CD2, CD3, and ganglioside GM1. Galectin-1 modulates cell growth and proliferation, either positively or negatively, depending on the cell type and activation status. It controls cell survival by inducing apoptosis of activated T cells and immature thymocytes. It modulates cytokine secretion by inducing Th2 type cytokines and inhibiting proinflammatory cytokine production. Galectin1 can also modulate cel-lcell as well as cell-lmatrix interactions and depending on the cell type and developmental stage, promote cell attachment or detachment. Galectin-1 has immunosuppressive and antiinflammatory properties and has been shown to suppress acute and chronic inflammation and autoimmunity. Human and mouse galectin1 share about 88% amino acid sequence similarity. |
|||
Human Galectin-1 (LGALS1) |
|||
| 1-CSB-EP012882HU | Cusabio |
|
|
|
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli |
|||
Human Galectin-1 (LGALS1) |
|||
| 1-CSB-EP012882HUb1 | Cusabio |
|
|
|
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli |
|||
human anti-human galectin-3 mAb(2D) |
|||
| E4A09H10-2D | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
human anti-human galectin-3 mAb(5F) |
|||
| E4A09H10-5F | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
human anti-human galectin-3 mAb(A5) |
|||
| E4A09H10-A5 | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
human anti-human galectin-3 mAb(G2) |
|||
| E4A09H10-G2 | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
human anti-human galectin-3 mAb(H3) |
|||
| E4A09H10-H3 | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
human anti-human galectin-3 mAb(T1) |
|||
| E4A09H10-T1 | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
Human Galectin-1 Protein |
|||
| PRP1033-100g | Abbkine | 100 µg | EUR 309 |
Human Galectin-1 Protein |
|||
| PRP1033-1mg | Abbkine | 1 mg | EUR 1099 |
Human Galectin-1 Protein |
|||
| PRP1033-20g | Abbkine | 20 µg | EUR 79 |
human anti-human galectin-3 mAb(N13) |
|||
| E4A09H10-N13 | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
Mouse anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543310-006mL | MyBiosource | 0.06mL | EUR 250 |
Mouse anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543310-012mL | MyBiosource | 0.12mL | EUR 370 |
Mouse anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543310-02mL | MyBiosource | 0.2mL | EUR 550 |
Anti Human Galectin-3 Polyclonal Antibody |
|||
| KH040 | Sceti | each | EUR 778.8 |
|
Description: The Anti Human Galectin-3 Polyclonal Antibody is available in Europe and for worldwide shipping via Gentaur. |
|||
Human Galectin-3(Galectin-3)ELISA Kit |
|||
| YLA0216HU-48T | Shanghai YL Biotech | 48T | Ask for price |
Human Galectin-3(Galectin-3)ELISA Kit |
|||
| YLA0216HU-96T | Shanghai YL Biotech | 96T | Ask for price |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543912-006mL | MyBiosource | 0.06mL | EUR 250 |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543912-012mL | MyBiosource | 0.12mL | EUR 370 |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543912-02mL | MyBiosource | 0.2mL | EUR 550 |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543913-006mL | MyBiosource | 0.06mL | EUR 250 |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543913-012mL | MyBiosource | 0.12mL | EUR 370 |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543913-02mL | MyBiosource | 0.2mL | EUR 550 |
Recombinant Human Galectin-1 |
|||
| 7-00427 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Galectin-1 |
|||
| 7-00428 | CHI Scientific | 50µg | Ask for price |
Recombinant Human Galectin-1 |
|||
| 7-00429 | CHI Scientific | 1mg | Ask for price |
Recombinant Human Galectin-1 |
|||
| AP60482 | SAB | 100ug | EUR 449 |
Recombinant Human Galectin-1 |
|||
| cyt-544-10g | ProSpec Tany | 10µg | EUR 60 |
Recombinant Human Galectin-1 |
|||
| cyt-544-1mg | ProSpec Tany | 1mg | EUR 1350 |
Recombinant Human Galectin-1 |
|||
| cyt-544-50g | ProSpec Tany | 50µg | EUR 145 |
Recombinant Human Galectin-1 |
|||
| HEOPP-0710 | Cyagen | 10ug | Ask for price |
RECOMBINANT HUMAN GALECTIN-1 |
|||
| GWB-BEA2B0 | GenWay Biotech | 0.05 mg | Ask for price |
Recombinant Human Galectin-1 |
|||
| MBS143303-001mg | MyBiosource | 0.01mg | EUR 240 |
Recombinant Human Galectin-1 |
|||
| MBS143303-005mg | MyBiosource | 0.05mg | EUR 310 |
Recombinant Human Galectin-1 |
|||
| MBS143303-1mg | MyBiosource | 1mg | EUR 1515 |
Recombinant Human Galectin-1 |
|||
| MBS143303-5x1mg | MyBiosource | 5x1mg | EUR 6485 |
RECOMBINANT HUMAN GALECTIN-1 |
|||
| MBS232407-005mg | MyBiosource | 0.05mg | EUR 500 |
RECOMBINANT HUMAN GALECTIN-1 |
|||
| MBS232407-5x005mg | MyBiosource | 5x0.05mg | EUR 2070 |
Recombinant Human Galectin-1 |
|||
| MBS966052-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 255 |
Recombinant Human Galectin-1 |
|||
| MBS966052-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 405 |
Recombinant Human Galectin-1 |
|||
| MBS966052-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1425 |
Recombinant Human Galectin-1 |
|||
| MBS966052-5x1mgEColi | MyBiosource | 5x1mg(E-Coli) | EUR 6215 |
Recombinant Human Galectin-1 |
|||
| MBS9420409-002mg | MyBiosource | 0.02mg | EUR 285 |
Recombinant Human Galectin-1 |
|||
| MBS9420409-01mg | MyBiosource | 0.1mg | EUR 470 |
Recombinant Human Galectin-1 |
|||
| MBS9420409-1mg | MyBiosource | 1mg | EUR 1785 |
Recombinant Human Galectin-1 |
|||
| MBS9420409-5x1mg | MyBiosource | 5x1mg | EUR 7885 |
Recombinant Human Galectin-1 |
|||
| P1229-.01 | ApexBio | 10ug | EUR 108.8 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human Galectin-1 |
|||
| P1229-.1 | ApexBio | 10X10ug | EUR 450.4 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human Galectin-1 |
|||
| P1229-.5 | ApexBio | 50X10ug | EUR 1010.4 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Human Galectin 1 Protein |
|||
| 20-abx066725 | Abbexa |
|
|
Anti- Galectin-1 Antibody |
|||
| GWB-6F6392 | GenWay Biotech | 0.1 mg | Ask for price |
anti- Galectin-1 antibody |
|||
| FNab03314 | FN Test | 100µg | EUR 606.3 |
|
Description: Antibody raised against Galectin-1 |
|||
anti- Galectin-1 antibody |
|||
| FNab03315 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against Galectin-1 |
|||
Human Galectin-1 Antibody Pair Set |
|||
| ABPR-ZB244 | Creative Diagnostics | 5 plates, 15 plates | Ask for price |
|
Description: Quantitative determination of Human Galectin-1 |
|||
Galectin-1, human recombinant |
|||
| 4648-10 | Biovision | each | EUR 170.4 |
Galectin-1, human recombinant |
|||
| 4648-1000 | Biovision | each | EUR 1977.6 |
Galectin-1, human recombinant |
|||
| 4648-50 | Biovision | each | EUR 314.4 |
Galectin-1 (human), (recombinant) |
|||
| MBS567229-01mg | MyBiosource | 0.1mg | EUR 750 |
Galectin-1 (human), (recombinant) |
|||
| MBS567229-5x01mg | MyBiosource | 5x0.1mg | EUR 3320 |
Galectin-1 Human Recombinant |
|||
| rAP-2252 | Angio Proteomie | Inquiry | Ask for price |
Human Galectin-1 ELISA Kit |
|||
| EK5323 | SAB | 96 tests | EUR 599 |
Human Galectin-1 ELISA Kit |
|||
| IHULGALS1KT | Innovative research | each | EUR 702 |
|
Description: Human Galectin-1 ELISA Kit |
|||
Human Galectin-1 ELISA Kit |
|||
| MBS2883188-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3290 |
Human Galectin-1 ELISA Kit |
|||
| MBS2883188-48StripWells | MyBiosource | 48-Strip-Wells | EUR 340 |
Human Galectin-1 ELISA Kit |
|||
| MBS2883188-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1800 |
Human Galectin-1 ELISA Kit |
|||
| MBS2883188-96StripWells | MyBiosource | 96-Strip-Wells | EUR 435 |
Human Galectin-1 ELISA Kit |
|||
| MBS765403-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3900 |
Spread of the COVID-19 global pandemic highlights the urgent need to develop effective treatments or vaccines against SARS-CoV-2 infection.
The identification of novel antibodies to neutralize the virus is one of the approaches to fight COVID-19 . In particular, detect an antibody against the SARS-CoV-2 spike protein by building on knowledge about the existing structure of SARS-CoV-2 and learnings from previous SARS antibody generations.
Potent neutralizing antibodies often target the receptor interaction site in S1, disabling receptor interactions. The so-called spike protein of 2019-nCoV is used by the virus to dock to human cells. By targeting the protein, to prevent the infection.
COVID-19 patients developed SARS-CoV-2-specific NAbs at the convalescent phase of infection (SARS-CoV-2 NAbs were unable to cross-reactive with SARS-CoV virus). SARS-CoV -2 specific NAbs reached their peak in patients from day 10-15 after the onset of the disease and remained stable thereafter in the patients.
Antibodies targeting on different domains of S protein, including S1, RBD, and S2, may all contribute to the neutralization.
Neutralizing antibodies (NAbs) play important roles in virus clearance and have been considered as a key immune product for protection or treatment against viral diseases.
Virus-specific NAbs, induced through either infection or vaccination, can block viral infection .
NAbs confer immunity by deactivate viruses by block access to receptors used by the virus to enter host cells and bind to viral capsid and block uncoating of the viral genome .
The level of NAbs has been used as a gold standard to evaluate the efficacy of vaccines against smallpox, polio and influenza viruses .
Passive antibody therapy, such as plasma fusion, was successfully used to treat infectious viral diseases, including SARS-CoV virus, influenza viruses, and Ebola virus.
The efficacy of passive antibody therapy was associated with the concentration of NAbs in plasma or antibodies of recovered donors.
As the global pandemic of COVID-19 proceeds, transfusion of convalescent plasma or serum from recovered patients was also considered as a promising therapy for prophylaxis of infection or treatment of disease.
Highly variable levels of NAbs in the patients of COVID-19 indicated that convalescent plasma and serum from recovered donors should be titrated before use in passive antibody therapy, an easy task that can be performed using the PsV neutralization assay. The titers of NAbs were variable in different patients.
Elderly patients (60-80 ys) were more likely to induce higher titers of NAbs than younger patients.
A moderatepositive correlation was also observed between age and Nab titers confirming the important role of age in the generation of Nabs. The correlation of NAbs titers with age, lymphocyte counts, and blood CRP levels suggested that the interplay between virus and host immune response.
19 mm Diameter Tapped Titanium Tip |
|||
| 0-120-0012 | Biologics | 19 mm | EUR 639 |
19 mm Diameter Solid Titanium Tip |
|||
| 0-120-0013 | Biologics | 19 mm | EUR 570 |
25 mm Diameter Tapped Titanium Tip |
|||
| 0-120-0014 | Biologics | 25 mm | EUR 682 |
25 mm Diameter Solid Titanium Tip |
|||
| 0-120-0015 | Biologics | 25 mm | EUR 614 |
Flat Replaceable Tips 13 mm Diameter Flat Titanium Tip |
|||
| 0-120-0016 | Biologics | 13 mm | EUR 86 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
|||
Flat Replaceable Tips 19 mm Diameter Flat Titanium Tip |
|||
| 0-120-0017 | Biologics | 19 mm | EUR 92 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
|||
Flat Replaceable Tips 25 mm Diameter Flat Titanium Tip |
|||
| 0-120-0018 | Biologics | 25 mm | EUR 100 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
|||
Titanium Cup Tip, 250 ml |
|||
| 0-120-0019 | Biologics | 250 ml | EUR 1377 |
|
Description: includes Interface Washers |
|||
Microtube Tray, 8 Position (for 250 ml Cup Tip) |
|||
| 0-120-0021 | Biologics | each | EUR 113 |
|
Description: includes Interface Washers |
|||
Continuous Flow Chamber |
|||
| 0-120-0026 | Biologics | each | EUR 774 |
|
Description: includes Interface Washers |
|||
Interface Washers 1.5” Diameter, 5/Pkg |
|||
| 0-120-003 | Biologics | 1.5'' Diameter | EUR 31 |
13 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0032 | Biologics | 13 mm | EUR 301 |
13 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0033 | Biologics | 13 mm | EUR 362 |
19 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0034 | Biologics | 19 mm | EUR 315 |
19 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0035 | Biologics | 19 mm | EUR 375 |
25 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0036 | Biologics | 25 mm | EUR 328 |
25 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0037 | Biologics | 25 mm | EUR 389 |
KoldPod, 1.5ml Micro Tube |
|||
| 0-120-0038 | Biologics | 1.5 ml | EUR 152 |
|
Description: Thermo conductive tube pods |
|||
KoldPod, 15ml Conical Tube |
|||
| 0-120-0039 | Biologics | 15 ml | EUR 275 |
|
Description: Thermo conductive tube pods |
|||
KoldPod, 50ml Conical Tube |
|||
| 0-120-0040 | Biologics | 50 ml | EUR 290 |
|
Description: Thermo conductive tube pods |
|||
Model 150 V/T Ultrasonic Homogenizer |
|||
| 0-121-0002 | Biologics | 210-240V/50-60Hz | EUR 2920 |
|
Description: Delivers up to 150 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample processing processing. |
|||
Model 300 V/T Ultrasonic Homogenizer |
|||
| 0-122-0002 | Biologics | 210-240V/50-60Hz | EUR 3520 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample. |
|||
SONABOZ Sound Abating Chamber |
|||
| 0-125-0001 | Biologics | each | EUR 1020 |
|
Description: Reduces cavitational sound emitted during processing. |
|||
Model 3000 Ultrasonic Homogenizer |
|||
| 0-127-0002 | Biologics | 210-240V/50-60Hz | EUR 4120 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip and includes an intergrated Sound Abating Chmaber to reduce cavitational sound emitted during processing. The Timer and Duty Cycle function increase preciosion in sample. |
|||
Model 3000MP Ultrasonic Homogenizer |
|||
| 0-128-0002 | Biologics | 210-240V/50-60Hz | EUR 4720 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip with preciosion control from a microprocessor and a graphical user interface displayed on a large (145 mm) LCD display. The integrated Sound Abating Chamber reduces cavitational sound emitted during processing. |
|||
OMNICON® Zone Reader, 210-240V/50-60Hz |
|||
| 0-131-0002 | Biologics | 210-240V/50-60Hz | EUR 35200 |
|
Description: Designed to Perform multi-plate Assays on round 90/100mm Petri Dishes. The integrated LED illumination system provides transmitted light for brightfield and darkfield illumination of transparent media. |
|||
OMNI-Noculator Peni Cylinder Filler, 210-240V/50-60Hz |
|||
| 0-134-0002 | Biologics | 210-240V/50-60Hz | EUR 32200 |
|
Description: A robotic liquid handling system designed to dispense Peni Cylinders and fill Peni Cylinders with the corresponding antibiotic liquid sample. |
|||
Peni Cylinder Dispenser with Manual Hopper |
|||
| 0-144-0002 | Biologics | each | EUR 5406 |
|
Description: Dispenser can be configured to dispense 4 or 6 Peni Cylinders onto a petri dish. |
|||
Peni Cylinder Dispenser with Motorized Hopper, 100-240V/50-60Hz |
|||
| 0-144-0003 | Biologics | 100-240V/50-60Hz | EUR 6254 |
|
Description: The motorized hopper can be configured to dispense 4 or 6 Peni Cylinders onto a petri Dispenser can be disassembled for disinfection. |
|||
Stainless Steel Peni Cylinder with Flat Face |
|||
| 0-144-0005 | Biologics | 6mm I.D. x 8mm O.D. x 10mm Long | EUR 399 |
|
Description: sold in packages of 100 pieces |
|||
Stainless Steel Peni Cylinder with Chamfered Face |
|||
| 0-144-0006 | Biologics | 6mm I.D. x 8mm O.D. x 10mm Long | EUR 412 |
|
Description: sold in packages of 100 pieces |
|||
Custom development of ELISAs for other species or antibody isotypes not listed in the catalog. Custom testing of samples for IgG/IgM/IgA or total (IgG+IgM+IgA) |
|||
| 000-CUS | Alpha Diagnostics | Custom | EUR 602 |
Alpha-Bungarotoxin, CF®405S, 500 ug |
|||
| 00002 | Biotium | 1UG | EUR 527 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-bungarotoxin, CF405s |
|||
| 00002 | Cusabio | 500uG | EUR 594 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-Bungarotoxin, CF®405S, 500 ug |
|||
| 00002-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®405S 100ug |
|||
| 00002-100ug | Biotium | 100uG | EUR 132 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®680R, 500 ug |
|||
| 9-00003 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®680R, 500 ug |
|||
| 00003-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®680R 100ug |
|||
| 9-00003 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®640R, 500 ug |
|||
| 9-00004 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®640R, 500 ug |
|||
| 00004-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®640R 100ug |
|||
| 9-00004 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®488A, 500 ug |
|||
| 9-00005 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®488A, 500 ug |
|||
| 00005-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin CF®488A 100ug |
|||
| 9-00005 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®568, 500 ug |
|||
| 9-00006 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®568, 500 ug |
|||
| 00006-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®568 100ug |
|||
| 9-00006 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®594, 500 ug |
|||
| 9-00007 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®594, 500 ug |
|||
| 00007-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin CF®594 100ug |
|||
| 9-00007 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®633, 500 ug |
|||
| 9-00009 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®633, 500 ug |
|||
| 00009-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®633 100ug |
|||
| 9-00009 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
SARS-CoV-2 Indicator Cell Line for RNA Replication - GFP Reporter only |
|||
| 0001-PP-001 | IBT Bioservices | 1 cell line (can order x amount) | EUR 12000 |
|
Description: SARS-CoV-2 GFP reporter cell line using HEK293T (ACE2/TMPRSS2) cells |
|||
Alpha-Bungarotoxin, 1 mg |
|||
| 00010-1 | Biotium | 1MG | EUR 193 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, 1 mg |
|||
| 00010-1-1 | Biotium | EA | EUR 193 |
Fluorescein-Alpha-Bungarotoxin, 500 ug |
|||
| 00011 | Biotium | 500uG | EUR 376 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Fluorescein-Alpha-Bungarotoxin, 500 ug |
|||
| 00011-1 | Biotium | EA | EUR 376 |
Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|||
| 00012 | Biotium | 500uG | EUR 394 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|||
| 00012-1 | Biotium | EA | EUR 394 |
Fluorescein-alpha-bungarotoxin, 10x50ug |
|||
| 00013 | Biotium | 10ST | EUR 436 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Fluorescein-alpha-bungarotoxin, 10x50ug |
|||
| 00013-1 | Biotium | EA | EUR 436 |
Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|||
| 00014 | Biotium | 10ST | EUR 494 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|||
| 00014-1 | Biotium | EA | EUR 494 |
Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|||
| 00015 | Biotium | 500uG | EUR 494 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|||
| 00015-1 | Biotium | EA | EUR 494 |
Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|||
| 00016 | Biotium | 10ST | EUR 560 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|||
| 00016-1 | Biotium | EA | EUR 560 |
Biotin-XX-A-Bungarotoxin, 500 ug |
|||
| 00017 | Biotium | 500uG | EUR 455 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Biotin-XX-A-Bungarotoxin, 500 ug |
|||
| 00017-1 | Biotium | EA | EUR 455 |
Alpha-Bungarotoxin, CF®555, 500 ug |
|||
| 9-00018 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®555, 500 ug |
|||
| 00018-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®555 100ug |
|||
| 9-00018 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Acrylamide, Chemzymes Ultra Pure® |
|||
| 00019-100 | Polysciences Europe GmbH | 100g | EUR 101.52 |
|
Description: 79-06-1 |
|||
Acrylamide, Chemzymes Ultra Pure® |
|||
| 00019-500 | Polysciences Europe GmbH | 500g | EUR 270 |
|
Description: 79-06-1 |
|||
Biotin-cAMP, 1 mg |
|||
| 00020 | Biotium | 1MG | EUR 298 |
|
Description: N/A |
|||
Biotin-cAMP, 1 mg |
|||
| 00020-1 | Biotium | 20ST | EUR 298 |
|
Description: N/A |
|||
Biotin-cAMP, 50 ug |
|||
| 00020-1-1 | Biotium | EA | EUR 414 |
Biotin-cGMP, 1 mg |
|||
| 00021 | Biotium | 1MG | EUR 331 |
|
Description: N/A |
|||
Biotin-cGMP, 1 mg |
|||
| 00021-1 | Biotium | 20ST | EUR 331 |
|
Description: N/A |
|||
Biotin-cGMP, 20x50 ug |
|||
| 00021-1-1 | Biotium | EA | EUR 447 |
Cyanine 644-cAMP, 1 mg |
|||
| 00022 | Biotium | 1MG | EUR 496 |
|
Description: N/A |
|||